(Q42238330)
Statements
Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria (English)
Steven Le Gouill
Jill Tipping
Maureen Zivanovic
Damien Huglo
Franck Morschhauser
Sam Mayes
Ruth Pettengell
Mike Bayne
W David J Ryder
Fabrice Jardin